Fig. 9
From: A bioinspired supramolecular nanoprodrug for precision therapy of B-cell non-Hodgkin’s lymphoma
Pharmacokinetics and biodistribution studies. A Protocol for B-NHL (Raji cell) xenograft model and monitor process. B The drug concentration of different FA formulations in the plasma of B-NHL xenograft mice model. C Cumulative amount of FA in plasma by calculating the area under the curve (AUC). D The FA content in major organs of tumor-bearing mice treated with FA or F@TPSA after 24 h. All data are presented the mean ± SD (n = 6). *p < 0.05, ***p < 0.001